Revelation Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:REVB Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
08 Dec 23	SellUS$14,438	George Tidmarsh	Individual		925.7	US$15.60

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1944.9%.

Top 15 shareholders own 2.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0.98%	Sabby Management, LLC	42,226	US$31.4k	0%	0.31%
0.95%	UBS Asset Management AG	40,945	US$30.4k	49.8%	no data
0.31%	Susquehanna International Group, LLP, Asset Management Arm	13,258	US$9.8k	0%	no data
0.19%	Geode Capital Management, LLC	8,173	US$6.1k	-1.07%	no data
0.059%	Tower Research Capital Europe Limited	2,539	US$1.9k	-49.3%	no data
0.033%	George Tidmarsh	1,404	US$1.0k	0%	no data
0.017%	James Rolke	750	US$556.9	0%	no data
0.015%	Chester Zygmont	661	US$490.9	0%	no data
0.007%	Securities America Advisors, Inc.	300	US$222.8	0%	no data
0.0047%	The Vanguard Group, Inc.	201	US$149.2	0%	no data
0.0025%	Jennifer Carver	106	US$78.7	0%	no data
0.00096%	Jess Roper	41	US$30.6	0%	no data
0.00068%	Bank of America Corporation, Asset Management Arm	29	US$21.7	123%	no data
0.00014%	Morgan Stanley, Investment Banking and Brokerage Investments	6	US$4.5	20%	no data
0.00002%	Pom Investment Strategies, LLC	1	US$0.6	0%	no data